Clinical Video Shorts

Omega-3 and Omega-6, Blood Levels And Coronary Heart Disease Risk/Benefit Controversy

Robert Superko, MD and Michael Caulfield, PhD, discuss the current clinical research on the use of Omega-3 & 6 supplementation and their link to decreased risk of cardiovascular events, including sudden cardiac death. They also discuss the clinical management of patients including the use of the Omega-3 & 6, Fatty Acid laboratory test as a marker of cardiovascular risk.

presenter_1

H. Robert Superko, MD, FACC, FAHA, FAACVPR

Academic Associate and Senior Medical Advisor

Quest Diagnostics

presenter_2

Michael P. Caulfield, PhD

Senior Scientific Director,

Endocrinology and Cardiovascular Disease

Quest Diagnostics, Nichols Institute

Omega-3 Blood Levels and CHD Risk/Benefit — 6:39

What are the Controversies? — 5:29

Clarification by Measuring Blood Levels – Part 1 — 7:42

Clarification By Measuring Blood Levels Part 2 — 9:37

Laboratory Methods of Omega-3&6 Test — 5:37

Test Results Guidance and Report — 3:31

Conclusions — 1:15

Q&A — 7:15

( back to Cardiovascular Short-Subjects )